Skip to content

Insider · CIK 0001365618

Hove Anders D

Reports to the SEC for 12 companies · NEW YORK, NY

Transactions

50

Companies

12

Filings

9

CIK

0001365618

Forms 4 and 5

Insider transactions

50 trades
DateCompanyValue
2024-01-30ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award—
2022-12-15ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award—
2021-01-12ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award—
2018-03-01ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award—
2017-02-16ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award—
2016-06-24Anacor Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer—
2016-06-24Anacor Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer—
2016-06-24Anacor Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer—
2016-06-24Anacor Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer—
2016-06-24Anacor Pharmaceuticals, Inc.D Disposition to Issuer−$3.36M
2016-06-24Anacor Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer—
2016-06-24Anacor Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer—
2016-05-16Anacor Pharmaceuticals, Inc.S Sale−$7.16M
2016-05-16Anacor Pharmaceuticals, Inc.S Sale−$19.9M
2016-05-16Anacor Pharmaceuticals, Inc.S Sale−$8.21M
2016-04-14Anacor Pharmaceuticals, Inc.2.00% Convertible Senior Notes due 2021C Conversion—
2016-04-14Anacor Pharmaceuticals, Inc.C Conversion+$8M
2016-04-08Anacor Pharmaceuticals, Inc.S Sale−$28.6K
2016-04-08Anacor Pharmaceuticals, Inc.S Sale−$271K
2016-04-07Anacor Pharmaceuticals, Inc.S Sale−$7.23M
2016-04-07Anacor Pharmaceuticals, Inc.S Sale−$515K
2016-04-07Anacor Pharmaceuticals, Inc.S Sale−$14.8K
2016-04-07Anacor Pharmaceuticals, Inc.S Sale−$167K
2016-04-07Anacor Pharmaceuticals, Inc.S Sale−$938K
2016-04-07Anacor Pharmaceuticals, Inc.S Sale−$7.14M
2015-12-15Anacor Pharmaceuticals, Inc.S Sale−$100M
2015-12-11Anacor Pharmaceuticals, Inc.S Sale−$4.69M
2015-11-10Anacor Pharmaceuticals, Inc.S Sale−$10.4M
2015-11-10Anacor Pharmaceuticals, Inc.J Other—
2015-11-10Anacor Pharmaceuticals, Inc.J Other—
2015-11-03Anacor Pharmaceuticals, Inc.J Other—
2015-11-03Anacor Pharmaceuticals, Inc.J Other—
2015-11-03Anacor Pharmaceuticals, Inc.J Other—
2015-11-03Anacor Pharmaceuticals, Inc.J Other—
2015-10-06PDSBPDS Biotechnology CorpJ Other+$401K
2015-10-06PDSBPDS Biotechnology Corp · Series C-2 Convertible Preferred StockC Conversion—
2015-10-06PDSBPDS Biotechnology CorpP Purchase+$4.95M
2015-10-06PDSBPDS Biotechnology CorpC Conversion—
2015-06-09Anacor Pharmaceuticals, Inc.Stock Option (right to buy)A Award—
2015-06-09Anacor Pharmaceuticals, Inc.A Award—
2014-10-16Anacor Pharmaceuticals, Inc.2.00% Convertible Debentures due 2021A Award—
2014-10-16Anacor Pharmaceuticals, Inc.2.00% Convertible Senior Notes due 2021A Award—
2014-09-26Anacor Pharmaceuticals, Inc.S Sale−$500K
2014-09-19Anacor Pharmaceuticals, Inc.S Sale−$18.4M
2014-09-18Anacor Pharmaceuticals, Inc.S Sale−$37.3K
2014-09-16Anacor Pharmaceuticals, Inc.S Sale−$1.87M
2014-09-12Anacor Pharmaceuticals, Inc.S Sale−$375K
2013-11-15Anacor Pharmaceuticals, Inc.S Sale−$2.11M
2013-06-06Anacor Pharmaceuticals, Inc.Stock Option (right to buy)A Award—
2012-09-20Anacor Pharmaceuticals, Inc.S Sale−$121K